Mission
The Epilepsy Study Consortium is a collaborative group of scientific investigators from leading academic medical research centers focused on reducing the time it takes to bring effective therapies to patients with epilepsy. They work across various fields to enhance clinical trial methodologies, foster partnerships with industry and regulatory bodies, and streamline the research process to improve treatment outcomes.
Basic Information
Tax-Exempt
Founded in
2006
EIN
20-4950952
Total Assets
$1.784 million
UN Sustainable Development Goals Supported
This organization contributes to the following United Nations Sustainable Development Goals. See the SDG page for more information.
Showing 2 of 2 goals
At a Glance
Who We Are
An introduction to the Epilepsy Study Consortium and its members.
ETDD Symposium
A biennial symposium focused on advancing epilepsy therapies and diagnostics.
Collaborative Research
The importance of collaborative research in advancing new epilepsy therapies.
Impact Stats
100+
Number of Trials
Clinical Trials Conducted
Assisted with the design and conduct of more than 100 clinical trials since 2007.
8
Number of New Therapies
New Therapies Approved
Successfully brought 8 new anti-epileptic drugs and devices to market.
Upcoming Events
Epilepsy Therapies & Diagnostics Development XVIII Symposium
May 28-30, 2025
A symposium discussing new epilepsy therapies and diagnostics, aimed at expediting their development.
Learn MoreMIP Score (Beta)
The MIP Score is in beta! We'd love any feedback you may have.
The MIP Score and it's methodology is purely used as a way to visualize how a nonprofits public financial data compares against others. It doesn't reflect the unique circumstances and impact that a nonprofit has.The MIP Score should never be used to say one charity is better than another.
Overall Score
62
54
/100
Program Expense Ratio
97.65%
20
/20
Program Revenue Growth
105.97%
20
/20
Leverage Ratio
0
2
/20
Working Capital Ratio
0.9301
10
/20
Fundraising Efficiency
0
2
/20
Latest Filing Data: Form 990
Fiscal Year:2022
Source:Source: Self-reported by organization
Financial Details
Revenue
| Category | Amount | Percentage |
|---|---|---|
| Contributions, Gifts, and Grants | 621.7K | 29.21% |
| Program Services | 1.507M | 70.79% |
| Investment Income | 33 | 0.00% |
| Sales of Non-Inventory Assets | 0 | 0.00% |
| Other Notable Sources | 0 | 0.00% |
| Total Revenue | 2.128M | 100.00% |
